BWAYBrainsway Ltd.

Nasdaq brainsway.com


$ 5.80 $ 0.26 (4.68 %)    

Thursday, 02-May-2024 15:59:52 EDT
QQQ $ 429.07 $ 5.38 (1.28 %)
DIA $ 382.31 $ 3.34 (0.88 %)
SPY $ 505.01 $ 0.61 (0.12 %)
TLT $ 88.87 $ 0.31 (0.35 %)
GLD $ 213.12 $ -0.66 (-0.31 %)
$ 5.82
$ 5.68
$ 0.00 x 0
$ 0.00 x 0
$ 5.68 - $ 5.80
$ 1.38 - $ 7.62
37,669
na
96.73M
$ 1.18
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 brainsway-expands-deep-tms-access-in-israel-brainsway-has-steadily-increased-its-presence-in-the-country-with-11-recent-system-installations-driven-in-part-by-a-45-increase-in-reimbursement-rates

 BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasi...

 brainsway-announces-published-review-results-highlighting-potential-of-deep-tms-to-treat-parkinsons-disease

BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasiv...

 hc-wainwright--co-maintains-buy-on-brainsway-raises-price-target-to-13

HC Wainwright & Co. analyst Raghuram Selvaraju maintains BrainsWay (NASDAQ:BWAY) with a Buy and raises the price target ...

 brainsway-q4-sales-903m-beat-842m-estimate

BrainsWay (NASDAQ:BWAY) reported quarterly sales of $9.03 million which beat the analyst consensus estimate of $8.42 million by...

 earnings-scheduled-for-march-6-2024

Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue o...

 brainsway-earnings-preview
BrainsWay Earnings Preview
03/05/2024 18:02:20

 brainsway-announced-that-it-will-be-clinically-evaluating-its-stimulation-technology-in-two-new-feasibility-trials

The Company now aims to assess the potential clinical impact of this technology on patients in two newly launched feasibility s...

 oppenheimer-maintains-outperform-on-brainsway-raises-price-target-to-6

Oppenheimer analyst Steven Lichtman maintains BrainsWay (NASDAQ:BWAY) with a Outperform and raises the price target from $5....

 raymond-james-downgrades-brainsway-to-market-perform

Raymond James analyst Jayson Bedford downgrades BrainsWay (NASDAQ:BWAY) from Outperform to Market Perform.

 brainsway-q3-eps-001-beats-004-estimate-sales-830m-beat-773m-estimate

BrainsWay (NASDAQ:BWAY) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.04) by ...

 earnings-scheduled-for-november-15-2023

Companies Reporting Before The Bell • Codere Online Luxembourg (NASDAQ:CDRO) is likely to report earnings for its third quarte...

 preview-brainsways-earnings
Preview: BrainsWay's Earnings
11/14/2023 16:01:31

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION